BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5308435)

  • 1. [Some indices of chronocardiography in puerperants in prevention of hemorrhage with methylergometrine].
    Vinotradova TS; Sidorova IS; Krylova GV; Kastrubin EM
    Vopr Okhr Materin Det; 1969 Aug; 14(8):71-4. PubMed ID: 5308435
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of Methylergometrine on certain components of the blood coagulation and anticoagulation systems during the placental and early postnatal periods].
    Vishnevskiĭ AA; Revva-Sliusar' ZK
    Vopr Okhr Materin Det; 1970 May; 15(5):91. PubMed ID: 5310859
    [No Abstract]   [Full Text] [Related]  

  • 3. [Active management of the placental period with methylergometrine and extraction of the placenta by the umbilical cord].
    Vladov E
    Akush Ginekol (Sofiia); 1968; 7(3):243-52. PubMed ID: 5304082
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of hemorrhage during the placental period with methylergobrevin].
    Papazov B; Radonov D; Karag'ozov A; Stankov I
    Akush Ginekol (Sofiia); 1972; 11(2):118-22. PubMed ID: 4539880
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of bleeding during the placental period].
    Shturkalev I; Atanasov D
    Akush Ginekol (Sofiia); 1972; 11(4):291-7. PubMed ID: 4539951
    [No Abstract]   [Full Text] [Related]  

  • 6. [Our experience in the mass prevention by medication of hemorrhages during the placental period in a series of 7,000 deliveries].
    Shturkalev I; Iliev G; Belopitov B; Atanasov D
    Akush Ginekol (Sofiia); 1965; 4(3):169-75. PubMed ID: 5294543
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prophylactic use of methylergometrine and oxytocin in the placental and early puerperal stages].
    Zeinalova AG
    Akush Ginekol (Mosk); 1970 May; 46(5):71-4. PubMed ID: 5312468
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of methylergonovine on puerperal prolactin secretion.
    Weiss G; Klein S; Shenkman L; Kataoka K; Hollander CS
    Obstet Gynecol; 1975 Aug; 46(2):209-10. PubMed ID: 1080266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misoprostol versus methylergometrine: pharmacokinetics in human milk.
    Vogel D; Burkhardt T; Rentsch K; Schweer H; Watzer B; Zimmermann R; Von Mandach U
    Am J Obstet Gynecol; 2004 Dec; 191(6):2168-73. PubMed ID: 15592308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of postpartum hemorrhage by uterotonic agents: comparison of oxytocin and methylergometrine in the management of the third stage of labor.
    Fujimoto M; Takeuchi K; Sugimoto M; Maruo T
    Acta Obstet Gynecol Scand; 2006; 85(11):1310-4. PubMed ID: 17091409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biphasic active management of the 3d stage of labor in the aspect of hemorrhage prevention in the placental period and elimination of placental retainment due to impaction].
    Durek M; Pietkiewicz D; Suchocki S
    Pol Tyg Lek; 1973 Jun; 28(23):867-8. PubMed ID: 4541697
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical research with OCM-505; its effects on delivery in 106 parturient].
    Rozas A; Nobre NS; Barros HC; Balsamo S; Sampaio LF; Neme B
    Hospital (Rio J); 1966 Jul; 70(1):191-204. PubMed ID: 5296800
    [No Abstract]   [Full Text] [Related]  

  • 13. [Conduction of the placenta period in modern obstetrics. Association of general methylergobrevin prevention and cord-traction method].
    Wladov E
    Zentralbl Gynakol; 1971 Aug; 93(35):1203-13. PubMed ID: 5315511
    [No Abstract]   [Full Text] [Related]  

  • 14. Methylergometrine: comparison of plasma concentrations and clinical response of two brands.
    Allonen H; Juvakoski R; Kanto J; Laitinen S; Mäntylä R; Kleimola T
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):340-2. PubMed ID: 352975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylergometrine during the early puerperium; a prospective randomized double blind study.
    Andersen B; Andersen LL; Sørensen T
    Acta Obstet Gynecol Scand; 1998 Jan; 77(1):54-7. PubMed ID: 9492719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of prophylactic use of 15-methyl prostalglandin F2alpha in the active management of third stage of labour.
    Biswas A; Bal R; Kundu MK; Kyal A; Halder M
    J Indian Med Assoc; 2007 Sep; 105(9):506, 508-9. PubMed ID: 18338474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral misoprostol for the prevention of primary post-partum hemorrhage during third stage of labor.
    Enakpene CA; Morhason-Bello IO; Enakpene EO; Arowojolu AO; Omigbodun AO
    J Obstet Gynaecol Res; 2007 Dec; 33(6):810-7. PubMed ID: 18001447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing postpartum hemorrhage.
    Schen RJ
    Postgrad Med; 1966 Aug; 40(2):A170. PubMed ID: 5296426
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of methylergometrin in parturients with threatened hemorrhage].
    Sidorova IS
    Akush Ginekol (Mosk); 1970 Sep; 46(9):56-9. PubMed ID: 5313378
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experience with medicamentous prevention of bleeding during the 3d stage of labor, using oxytocin and methylergometrin].
    Zvarík E; Valentková M
    Cesk Gynekol; 1967 Aug; 32(6):496-8. PubMed ID: 5300589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.